Galium-68 EVS 459

N/A

Report date: 2025/12/01 17:52:15

Base Information

Drug NameGalium-68 EVS 459

Drug Alias Name[68Ga]Ga-EVS459

ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionRadionuclide imaging enhancersMagnetic resonance imaging enhancersPositron-emission tomography enhancers +[4]

TargetsFolate receptor alpha

Therapy Area/IndicationsLung NeoplasmsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovartis Pharma Ag

Active IndicationsN/A

Inactive IndicationsLung NeoplasmsOvarian Neoplasms

Other Information

ATC CodeN/A